Skip to main content

Table 4 HLA-DR antigen frequency among individuals with ESRD and healthy controls

From: Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study

 

Patients N = 141

Control N = 190

    

Antigens

Count

Antigen frequency

Count

Antigen frequency

Odds ratio

95 % confidence interval (95 % CI)

P value

Corrected P value

DR1

  

3

1.6 %

0.19

0.010–3.695

NS

 

DR3

35

24.8 %

28

14.7 %

1.91

1.098–3.324

0.024

0.312

DR4

48

34.0 %

54

28.4 %

1.30

0.813–2.079

NS

 

DR7

9

6.4 %

4

2.1 %

3.17

0.956–10.513

NS

 

DR8

13

9.2 %

34

17.9 %

0.47

0.236–0.920

0.027

0.351

DR9

44

31.2 %

56

29.5 %

1.09

0.676–1.743

NS

 

DR10

6

4.3 %

4

2.1 %

2.07

0.572–7.466

NS

 

DR11

30

21.3 %

22

11.6 %

2.06

1.133–3.761

0.021

0.273

DR12

29

20.6 %

48

25.3 %

0.77

0.454–1.292

NS

 

DR13

6

4.3 %

17

8.9 %

0.45

0.174–1.178

NS

 

DR14

14

9.9 %

25

13.2 %

0.73

0.364–1.456

NS

 

DR15

24

17.0 %

36

18.9 %

0.88

0.496–1.551

NS

 

DR16

10

7.1 %

25

13.2 %

0.50

0.23–1.086

NS

 
  1. N number, NS not significant
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us